Moreover, infusion therapy to psoriatic patients with CD3+CD56+ NKT cells (which likely consist of CD1d-restricted NKT cells) restored CD3+CD56+ NKT cell levels in patient PBMCs, leading to improved skin lesions in severe psoriasis (56). This evidence concerns the gene NCAM1 and psoriasis.